Upper extremity 3-dimensional reachable workspace assessment in amyotrophic lateral sclerosis by Kinect sensor

ABSTRACT Introduction: Reachable workspace is a measure that provides clinically meaningful information regarding arm function. In this study, a Kinect sensor was used to determine the spectrum of 3‐dimensional reachable workspace encountered in a cross‐sectional cohort of individuals with amyotroph...

Full description

Saved in:
Bibliographic Details
Published inMuscle & nerve Vol. 53; no. 2; pp. 234 - 241
Main Authors Oskarsson, Bjorn, Joyce, Nanette C., De Bie, Evan, Nicorici, Alina, Bajcsy, Ruzena, Kurillo, Gregorij, Han, Jay J.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.02.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACT Introduction: Reachable workspace is a measure that provides clinically meaningful information regarding arm function. In this study, a Kinect sensor was used to determine the spectrum of 3‐dimensional reachable workspace encountered in a cross‐sectional cohort of individuals with amyotrophic lateral sclerosis (ALS). Methods: Bilateral 3D reachable workspace was recorded from 10 subjects with ALS and 17 healthy controls. The data were normalized by each individual's arm length to obtain a reachable workspace relative surface area (RSA). Concurrent validity was assessed by correlation with scoring on the ALS Functional Rating Score—revised (ALSFRSr). Results: The Kinect‐measured reachable workspace RSA differed significantly between the ALS and control subjects (0.579 ± 0.226 vs. 0.786 ± 0.069; P < 0.001). The RSA demonstrated correlation with ALSFRSr upper extremity items (Spearman correlation ρ = 0.569; P = 0.009). With worsening upper extremity function, as categorized by the ALSFRSr, the reachable workspace also decreased progressively. Conclusions: This study demonstrates the feasibility and potential of using a novel Kinect‐based reachable workspace outcome measure in ALS. Muscle Nerve 53: 234–241, 2016
Bibliography:The National Institutes of Health (NIH) - No. NIAMS U01 AR065113-01
ark:/67375/WNG-1ZF5TMKT-S
The U.S. Department of Education - No. NIDRR H133B090001
B.O. and N.C.J. were supported by grants from the NIH - No. UL1 TR000002; No. KL2 TR000134 to B.O.; No. NIH 5K12HD001097-15 to N.C.J
The National Science Foundation - No. 1111965
istex:F467032D733EAF49FD074B556FCCA1F12FCDF6DC
ArticleID:MUS24703
The first 2 authors (B.O. and N.C.J.) share joint first authorship.
This research was supported in part by grants from the U.S. Department of Education (NIDRR H133B090001); and the National Science Foundation (1111965). B.O. and N.C.J. were supported by grants from the NIH (UL1 TR000002 and KL2 TR000134 to B.O., NIH 5K12HD001097‐15 to N.C.J.).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0148-639X
1097-4598
1097-4598
DOI:10.1002/mus.24703